-
Shape-shifter’s structure regulates activity
Structural biologists have discovered new information about an enzyme called Abl that can affect patients with chronic myeloid leukemia and other cancers.
-
Antibiotic reduces infection risk in leukemia patients
Recent St. Jude research suggests that combining an anti-malaria medication with a cancer medication may help improve treatment response in patients with a rare subtype of acute lymphoblastic lymphoma.
-
Anti-malaria drug paves way for targeted therapy
Recent St. Jude research suggests that combining an anti-malaria medication with a cancer medication may help improve treatment response in patients with a rare subtype of acute lymphoblastic lymphoma.
-
Discovery offers insight into disease origins
New research suggests that blood-forming stem cells may have a greater impact on the development of leukemia and other blood disorders than previously thought.
-
The path to precision
Researchers studying precision medicines for brain tumor treatments have made an exciting discovery for patients with the medulloblastoma subtype.
-
Young leukemia patients need extra flu protection
Patients with acute leukemia may still be at risk for developing flu or flu-like symptoms even if they have been vaccinated.
-
Teen cancer patients may benefit from more support
Many St. Jude patients have felt the loss of someone close to them, yet few have talked to someone about their grief.
From Promise, Winter 2018